## Background: Behavioural and psychological symptoms of dementia (bpsd) cannot be regarded as a single clinical syndrome, but rather as a heterogeneous group of symptoms, each of which can be considered as possible targets for therapy. ## Objective: To compare the efficacy of risperidone and hal
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
โ Scribed by Jeffrey L. Cummings
- Book ID
- 107550349
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 43 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1523-3812
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Dear Editor I feel I cannot let the assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia (Suh et al., 2006) go unchallenged. This paper shows no such thing. There is a very basic flaw, which means that all findings are invali
## Objective: To evaluate the efficacy and safety of low-dose risperidone in treating psychosis of alzheimer's disease (ad) and mixed dementia (md) in a subset of nursing-home residents who had dementia and aggression and who were participating in a randomized placebo-controlled trial of risperidon